GlaxoSmithKline Pharmaceuticals Ltd. - GLAXO, 500660 corporate action history

Ex-Date	Bonus Ratio	Record Date
11 Sep 2018	1:1	13 Sep 2018

See all forthcoming Bonus and Splits

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
30 May 2025	42.00	FINAL	30 May 2025	Equity Share
07 Nov 2024	12.00	INTERIM	07 Nov 2024	Equity Share
31 May 2024	32.00	FINAL	31 May 2024	Equity Share
30 Jun 2023	32.00	FINAL	30 Jun 2023	Equity Share
07 Jul 2022	60.00	SPECIAL	08 Jul 2022	Equity Share
07 Jul 2022	30.00	FINAL	08 Jul 2022	Equity Share
19 Jul 2021	30.00	FINAL	20 Jul 2021	Equity Share
17 Jul 2020	20.00	SPECIAL	20 Jul 2020	Equity Share
17 Jul 2020	20.00	FINAL	20 Jul 2020	Equity Share
11 Jul 2019	20.00	FINAL	-	Equity Share
13 Jul 2018	35.00	FINAL	-	Equity Share
14 Jul 2017	30.00	FINAL	-	Equity Share
15 Jul 2016	50.00	FINAL	-	Equity Share
23 Jul 2015	62.50	FINAL	-	Equity Share
03 Apr 2014	50.00	FINAL	-	Equity Share
04 Apr 2013	50.00	FINAL	-	Equity Share
29 Mar 2012	45.00	FINAL	-	Equity Share
14 Mar 2011	40.00	FINAL	-	Equity Share
10 Mar 2010	30.00	FINAL	-	Equity Share
18 Mar 2009	40.00	FINAL	-	Equity Share
02 Apr 2008	36.00	FINAL	-	Equity Share
14 Mar 2007	31.00	FINAL	-	Equity Share
24 Mar 2006	28.00	FINAL	-	Equity Share
16 Mar 2005	24.00	FINAL	-	Equity Share
25 Feb 2004	10.00	FINAL	-	Equity Share
10 Apr 2003	7.00	FINAL	-	Equity Share

Ex-Date	Purpose	Notes
01 Aug 2025	Quarterly Results	-
13 May 2025	Audited Results & Final Dividend	-
14 Feb 2025	Quarterly Results	(Revised)
29 Oct 2024	Quarterly Results & Interim Dividend	-
02 Aug 2024	Quarterly Results	-
17 May 2024	Audited Results & Final Dividend	-
12 Feb 2024	Quarterly Results	-
09 Nov 2023	Quarterly Results	-
26 Jul 2023	Quarterly Results	-
17 May 2023	Audited Results & Final Dividend	-

Ex-Date	Ratio	Face Value	Premium	Record Date
21 May 1993	1.0:5.0	0.0	55.0	15 Jun 1993